Detalhe da pesquisa
1.
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
Gynecol Oncol
; 152(1): 53-60, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449719
2.
Long chain fatty acids analysis of intertidal biofilm by direct injection liquid chromatography time of flight mass spectrometry.
J Chromatogr A
; 1693: 463870, 2023 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848732
3.
Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel.
Pharmacoeconomics
; 39(9): 1021-1044, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231135
4.
Detailed investigations into the Akabori-Momotani reaction for the synthesis of amphetamine type stimulants: Part 2.
Forensic Sci Int
; 287: 207-216, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459189
5.
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.
Oncotarget
; 8(31): 50930-50940, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881617
6.
Nurse-Led Telephone Follow-up: Improving Options for Women With Endometrial Cancer.
Cancer Nurs
; 38(3): 232-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25098923
7.
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.
Oncoimmunology
; 4(11): e1032492, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26451312